American Cancer Society

OrganisationROR

Trials

Sources: clinicaltrials.gov

Awards made

  • Sharon Stack

    Oncoaging and Ovarian Cancer Metastatic Success, DBG-26-1612865-01-MM-W25, 2026–2028, 1 Oct 2026

  • University of Notre Dame

    Oncoaging and Ovarian Cancer Metastatic Success, DBG-26-1612865-01-MM-W25, 297k, 2026–2028, 1 Oct 2026

  • Peter Mullen

    The impact of aging on bladder cancer, RSG-26-1616464-01-CCB-W25, 2026–2030, 1 Oct 2026

  • University of Southern California

    The impact of aging on bladder cancer, RSG-26-1616464-01-CCB-W25, 946k, 2026–2030, 1 Oct 2026

  • Luigi Perelli

    Targeting Early Events in Kidney Cancer - Integrating metabolism and immune surveillance for prevention, ACPA-26-1601996-01-ACS CRUK W25, 2026–2031, 1 Aug 2026

  • The University of Texas MD Anderson Cancer Center

    Targeting Early Events in Kidney Cancer - Integrating metabolism and immune surveillance for prevention, ACPA-26-1601996-01-ACS CRUK W25, 928k, 2026–2031, 1 Aug 2026

  • Brandon Mahal

    Developing a Targeted Community-Based Precision PSA Screening and Cohort Registry to Address Prostate Cancer Disparities, RSG-25-1529571-01-ESED, 2026–2030, 1 Apr 2026

  • University of Miami

    Developing a Targeted Community-Based Precision PSA Screening and Cohort Registry to Address Prostate Cancer Disparities, RSG-25-1529571-01-ESED, 946k, 2026–2030, 1 Apr 2026

  • Emily Williams

    Adaptation and Pilot Testing of an Avatar-Delivered Alcohol Reduction Intervention for Women at Risk for Incidence and Recurrence of Breast Cancer, DBG-25-1515707-01-CPHP, 2026–2028, 1 Apr 2026

  • University of Washington

    Adaptation and Pilot Testing of an Avatar-Delivered Alcohol Reduction Intervention for Women at Risk for Incidence and Recurrence of Breast Cancer, DBG-25-1515707-01-CPHP, 297k, 2026–2028, 1 Apr 2026

  • Qing Luo

    Harnessing ecDNA amplification signals in plasma whole genome for cancer detection, PF-25-1505281-01-PFCDET, 2026–2029, 1 Apr 2026

  • Weill Cornell Medicine

    Harnessing ecDNA amplification signals in plasma whole genome for cancer detection, PF-25-1505281-01-PFCDET, 2026–2029, 1 Apr 2026

  • Cornell University

    Harnessing ecDNA amplification signals in plasma whole genome for cancer detection, PF-25-1505281-01-PFCDET, 217.5k, 2026–2029, Lead, 1 Apr 2026

  • Karly Murphy

    Implementation of a communication and linkage intervention to improve the breast cancer screening cascade among women with serious mental illness, CSDG-25-1511113-01-HOPS, 2026–2031, 1 Apr 2026

  • Regent University

    Implementation of a communication and linkage intervention to improve the breast cancer screening cascade among women with serious mental illness, CSDG-25-1511113-01-HOPS, 729k, 2026–2031, 1 Apr 2026

  • Beau Abar

    Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling, DBG-25-1374559-01-ESED, 2025–2027, 1 Nov 2025

  • University of Rochester Medicine

    Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling, DBG-25-1374559-01-ESED, 297k, 2025–2027, 1 Nov 2025

  • Jenna Canzoniero

    Improving breast cancer early detection with ctDNA fragmentomics, RSG-25-1420837-01-ESED, 2025–2029, 1 Sept 2025

  • Johns Hopkins University

    Improving breast cancer early detection with ctDNA fragmentomics, RSG-25-1420837-01-ESED, 946k, 2025–2029, 1 Sept 2025

  • Trisha Amboree

    An MUSC System-wide Assessment of Cervical Cancer Screening Practices to Enhance Cervical Cancer Prevention in South Carolina, IRG-24-1290553-23-IRG-04, 2025–2026, 1 Mar 2025

Sources: openalex.org

Funded papers

Sources: pubmed.ncbi.nlm.nih.gov, api.crossref.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers